前收市價 | 29.70 |
開市 | 30.49 |
買盤 | 0.00 x 30000 |
賣出價 | 0.00 x 30000 |
今日波幅 | 30.49 - 30.49 |
52 週波幅 | 24.08 - 36.25 |
成交量 | |
平均成交量 | 4 |
市值 | 4.132B |
Beta 值 (5 年,每月) | 0.65 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -0.03 |
業績公佈日 | 無 |
遠期股息及收益率 | 1.01 (3.31%) |
除息日 | 2024年3月07日 |
1 年預測目標價 | 51.00 |
Perrigo's (PRGO) new products and products added through acquisitions are expected to have aided the top line in the soon-to-be-reported quarter.
Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The portfolio had a 5.7% gain in the first quarter compared to an 8.2% return in the Russell Midcap Value Index. The Strategy underperformed in Financials and Industrials due […]
Pharma company Perrigo plans to spread the word about Opill at the WNBA draft.